DANISH HANGORA: Open Payments
NPI 1396146833 · JOLIET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 43 payments from 11 companies in 2025. Trend: 2023 $187 · 2024 $495 · 2025 $792
Food & beverage: $747Education: $44
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $229 |
| E.R. Squibb & Sons, L.L.C. | 14 | $209 |
| Neurocrine BioSciences, Inc. | 5 | $97 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| Alkermes, Inc. | 3 | $61 |
| ABBVIE INC. | 1 | $27 |
| Braeburn Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: COBENFY, ABILIFY ASIMTUFII, INGREZZA, REXULTI, INVEGA SUSTENNA, LYBALVI, ABILIFY MAINTENA, VRAYLAR.
Industry payments across IL — which companies pay providers there.
